Effects of catecholamines on sympathetic evoked action potentials in the stellate ganglion of the cat.
D000200:Action Potentials / Q000187:drug effects*; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001237:Asphyxia / Q000503:physiopathology; D002395:Catecholamines / Q000494:pharmacology*; D002415:Cats; D003864:Depression, Chemical; D004558:Electric Stimulation; D004837:Epinephrine / Q000494:pharmacology; D005071:Evoked Potentials / Q000187:drug effects*; D005260:Female; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008729:Methoxamine / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D013233:Stellate Ganglion / Q000187:drug effects* / Q000502:physiology; D013564:Sympathetic Nervous System / Q000502:physiology*; D013757:Tetraethylammonium Compounds / Q000494:pharmacology; D014439:Tyramine / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D013757:Tetraethylammonium Compounds; D010656:Phenylephrine; D008729:Methoxamine; D007545:Isoproterenol; D009638:Norepinephrine; D014439:Tyramine; D004837:Epinephrine